Waverley Pharma Inc. (TSXV:WAVE)
0.0300
0.00 (0.00%)
At close: Jan 16, 2026
Waverley Pharma Revenue
Waverley Pharma had revenue of 275.66K CAD in the quarter ending September 30, 2025, with 1,129.68% growth. This brings the company's revenue in the last twelve months to 1.51M, up 2,016.26% year-over-year. In the year 2024, Waverley Pharma had annual revenue of 475.37K with 15.36% growth.
Revenue (ttm)
1.51M
Revenue Growth
+2,016.26%
P/S Ratio
1.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 475.37K | 63.28K | 15.36% |
| Dec 31, 2023 | 412.09K | -834.74K | -66.95% |
| Dec 31, 2022 | 1.25M | -506.02K | -28.87% |
| Dec 31, 2021 | 1.75M | 377.74K | 27.47% |
| Dec 31, 2020 | 1.38M | 217.83K | 18.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| DRI Healthcare Trust | 270.19M |